Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.26 USD
−10.56 M USD
245.70 M USD
About PHARMING GROUP
Sector
CEO
Sijmen de Vries
Headquarters
Leiden
Website
Founded
2019
FIGI
BBG00YN70VB3
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
